Previous 10 | Next 10 |
Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results PR Newswire HAYWARD, Calif. , Sept. 20, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene t...
Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference PR Newswire HAYWARD, Calif. , Sept. 13, 2021 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company develo...
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022 PR Newswire HAYWARD, Calif. , Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of...
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals PR Newswire HAYWARD, Calif. , Sept. 8, 2021 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancem...
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 PR Newswire HAYWARD, Calif. , Sept. 8, 2021 /PRNewswire/ -- Regulatory Update Highlights: ...
Palisade Bio (PALI) +36% on FDA's fast track designation for LB1148.Fuel Tech (FTEK) +21% on Q1 results.Lianluo Smart (LLIT) +20%.Celyad Oncology SA (CYAD) +20%.Vertex Energy (VTNR) +18% on Q1 results.InnSuites Hospitality Trust (IHT) +15%.Heron Therapeutics (HRTX) +15% on...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...
Gainers: ADMA Biologics (ADMA) +25%, Brooklyn ImmunoTherapeutics (BTX) +23%, Clover Health Investments (CLOV) +15%, Neptune Wellness Solutions (NEPT) +12%, Akouos (AKUS) +11%.Losers: Protalix BioTherapeutics (PLX) -40%, Benitec Bioph...
Protalix BioTherapeutics (PLX) -43% on FDA rejection of experimental therapy for Fabry disease.Benitec Biopharma (BNTC) -22% after secures $13M capital via equity offering.Urban Tea (MYT) -13% on 1H earnings releasePinterest (PINS) -12% on Q1 earnings releas...
Benitec Biopharma's (BNTC) underwriter has agreed to increase the size of the previous offering and purchase on a firm commitment basis ~3M shares of common stock at $4.25/share.Expected gross proceeds are ~$12.9MUnderwriter's over-allotment is an additional ~455.5K shares. Net proceeds will ...
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
Benitec Biopharma Limited Website:
2024-07-16 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-The post-dose average values for Total Pharyngeal Residue (i.e., the amount of solid food or liquid material remaining in the pharynx after the first swallow) remained meaningfully reduced at the 180-day post-dose assessment following the administration of the low dose of gene therapy BB-301 as ...
HAYWARD, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace ...